Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Bemis Company Elects Krempa Vice President and Controller

Bemis Company, Inc. announced today that its Board of Directors has promoted Jerry S. Krempa to Vice President and Controller of Bemis Company, Inc., reporting to Scott Ullem, Bemis' Chief Financial Officer.

Krempa succeeds Stanley A. Jaffy, who will assume the role of Vice President of Finance.

Krempa joined Bemis in 1998 as Corporate Director of Tax and was promoted to Assistant Controller in 2007. Prior to joining Bemis, he held tax positions at the public accounting firms of KPMG and PricewaterhouseCoopers. Krempa is a CPA and received both his Bachelor of Science degree in accounting and his Masters of Science in Taxation degree from DePaul University.

"Jerry has been an integral part of the Bemis financial management team for many years, and I look forward to his continued leadership and contributions to the future growth of Bemis Company," said Henry Theisen, President and Chief Executive Officer of Bemis Company. "Stan has served as Bemis' Vice President and Controller for the past 9 years and has done an outstanding job of navigating Bemis through a period of dramatic change in accounting and regulatory requirements. In his new role, he will continue to be an important member of our leadership team."
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?